Delivery Order SPE2DB25D3017-SPE2DB25FVHZM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,288.59 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection). This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 29, 2025, issued on April 28, 2025. AmerisourceBergen will perform and deliver from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,575.97 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections (2.24 mL units). This firm fixed-price contract, awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, was competitively awarded with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a FDA-approved medication used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,833.32 on September 3, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is set to complete by September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a ceiling value of $16,198.68. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively awarded. The pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,537.36 to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on September 10, 2025, with completion scheduled for September 11, 2025. The contract utilized firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $30,571.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on May 14, 2025, with completion targeted for May 15, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $16,156.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $51,719.69 delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVHZMDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $8,579.78 on May 6, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by May 7, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contracts predominantly with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to support defense and veteran healthcare systems. This delivery order for Forteo, an osteoporosis treatment medication, represents a routine pharmaceutical supply transaction under the broader global pharmaceutical support vehicle that enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/6/25 |